Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds
GOTHENBURG, Sweden, Oct. 21, 2025 /PRNewswire/ -- "We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company's ...
Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions
GOTHENBURG, Sweden, July 18, 2025 /PRNewswire/ -- "The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects," says Mattias Perjos, President & ...
Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward
GOTHENBURG, Sweden, April 22, 2025 /PRNewswire/ -- "We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 6.2...
Getinge publishes Annual Report for 2024
GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has r...
Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins
GOTHENBURG, Sweden, Jan. 28, 2025 /PRNewswire/ -- "In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions", says Mattias Perjos, CEO of Getinge. Grow...
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings
GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased by 3.5%, of which the organic increase...
Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market
Today, Getinge announces an agreement to acquire 100% of Paragonix Technologies, Inc., a leading organ transport products and services company in the United States for an aggregated purchase price, including upfront and earn out payments, estimated to approximatelyUSD 477 million. GOTHENBURG, Swe...
Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average
GOTHENBURG, Sweden, May 15, 2024 /PRNewswire/ -- Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today's decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to heal...
Getinge Interim Report January-March 2022: Healthy order book but supply chain challenges
GOTHENBURG, Sweden, April 26, 2022 /PRNewswire/ -- "Net sales declined by 6.4% and the order intake fell organically by 4.4% in the quarter," says Mattias Perjos, President & CEO. "However, excluding the strong sales of ventilators in 2021, we had organic growth in both order intake and net sales...
Getinge Year End Report 2021: "Healthy order growth, improved EBITA margin and strong cash flow"
GOTHENBURG, Sweden, Jan. 28, 2022 /PRNewswire/ -- "The organic order intake increased 6.4% in the fourth quarter following growth in all business areas and regions", says Mattias Perjos, President & CEO at Getinge. "Excluding currency effects, our order bookings are more than 20% larger compared ...
Getinge accelerates growth and productivity to reach new financial targets
GOTHENBURG, Sweden, Nov. 22, 2021 /PRNewswire/ -- "Getinge's new financial targets for 2022-2025, an annual organic net sales growth of 4-6% and adjusted EPS growth of above 10% on average throughout the period, is well in line with our strategy and ambitions", says Mattias Perjos, President & CE...
Getinge Q3 Report 2021: "Strong order intake and our remediation measures completed in Germany"
GOTHENBURG, Sweden, Oct. 20, 2021 /PRNewswire/ -- "Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at Getinge. "Our cash flow remains strong, meaning that we have strengthened ...
Getinge Interim Report January-June 2021: Strong recovery in products for surgery
GETINGE, Sweden, July 16, 2021 /PRNewswire/ -- "In total, sales increased by 3.6% organically compared with the second quarter 2020, and the order intake declined by 6.1% organically compared with 2020 when we received very large orders of advanced ICU ventilators", says Mattias Perjos, President...
Getinge introduces a long-term flexible workplace approach
GOTHENBURG, Sweden, March 29, 2021 /PRNewswire/ -- Three out of four Getinge employees who have worked from home during the COVID-19 pandemic believe that the setup has improved their productivity as well as their work-life harmony. As a result, the company is introducing a long-term flexible wor...
Getinge launches NICCI - the latest innovation in Advanced Hemodynamic Monitoring
- NICCI is Getinge's latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure GOTHENBURG, Sweden, Oct. 26, 2020 /PRNewswire/ -- Blood pressure is one of the most...
The ventilation technology from Getinge that is groundbreaking both for premature babies and adults
GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- Born 12 weeks too early with a 50/50 chance at survival,Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and sophisticated technology to improve outcomes for premature babies. One such technique called NAVA, ...
Independent multi-center trial shows that Getinge's NAVA ventilation mode shortens time of mechanical ventilation by almost 35% for adult ICU patients
GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- The clinical effectiveness of Getinge's patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient's own respiratory drive to control ventilator assistance, is supported in the NAVIATOR trial. According to the NAVIATOR trial, N...
Getinge and partners showcase connectivity solutions for the quiet ICU of the future
GOTHENBURG, Sweden, Sept. 9, 2020 /PRNewswire/ -- Together with leading industry partners, Getinge is showcasing innovative connectivity solutions for creating a more quiet and healing environment for the intensive care unit (ICU). By distributing audible alarms outside patient rooms, ICUs will b...
Getinge Interim Report January-June 2020: Making a Real Difference Together With our Customers
GOTHENBURG, Sweden, July 16, 2020 /PRNewswire/ -- "During this year's second quarter, we report a continued strong order intake and net sales of advanced ICU ventilators and ECMO therapy products for hospitals and Sterile Transfer products for the pharmaceutical industry," says Mattias Perjos, Pr...
Getinge Interim Report for January-March 2020: Intense Efforts to Help Hospitals in the COVID-19 Pandemic
GOTHENBURG, Sweden, April 22, 2020 /PRNewswire/ -- "The quarter was dominated by the COVID-19 pandemic and the huge need for advanced ventilators and ECMO therapy at intensive care units around the world. Our leading global positions in these fields contributed to a 47% organic order growth, says...
